Palliative care consultation in patients with Staphylococcus aureus bacteremia

Takaaki Kobayashi, Jorge L. Salinas, Patrick Ten Eyck, Benjamin Chen, Tomo Ando, Kengo Inagaki, Mohammed Alsuhaibani, Paul G. Auwaerter, Ilonka Molano, Daniel J. Diekema

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Palliative care consultation has shown benefits across a wide spectrum of diseases, but the utility in patients with Staphylococcus aureus bacteremia remains unclear despite its high mortality. Aim: To examine the frequency of palliative care consultation and factors associated with palliative care consult in Staphylococcus aureus bacteremia patients in the United States. Design: A population-based retrospective analysis using the Nationwide Inpatient Sample database in 2014, compiled by the Healthcare Costs and Utilization Project of the Agency for Healthcare Research and Quality. Setting/subjects: All inpatients with a discharge diagnosis of Staphylococcus aureus bacteremia (ICD-9-CM codes; 038.11 and 038.12). Measurements: Palliative care consultation was identified using ICD-9-CM code V66.7. Patients’ baseline characteristics and outcomes were compared between those with and without palliative care consult. Results: A total of 111,320 Staphylococcus aureus bacteremia admissions were identified in 2014. Palliative care consult was observed in 8140 admissions (7.3%). Palliative care consultation was associated with advanced age, white race, comorbidities, higher income, teaching/urban hospitals, Midwest region, Methicillin-resistant Staphylococcus aureus bacteremia and the lack of echocardiogram. Palliative care consult was also associated with shorter but more expensive hospitalizations. Crude mortality was 53% (4314/8140) among admissions with palliative care consult and 8% (8357/10,3180) among those without palliative care consult (p < 0.001). Conclusions: Palliative care consultation was infrequent during the management of Staphylococcus aureus bacteremia, and a substantial number of patients died during their hospitalizations without palliative care consult. Given the reported benefit in other medical conditions, palliative care consultation may have a role in Staphylococcus aureus bacteremia. Selecting patients who may benefit the most should be explored.

Original languageEnglish (US)
Pages (from-to)785-792
Number of pages8
JournalPalliative Medicine
Volume35
Issue number4
DOIs
StatePublished - Apr 2021

Keywords

  • Staphylococcus bacteremia
  • mortality
  • palliative care consultation
  • staphylococcus aureus

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Palliative care consultation in patients with Staphylococcus aureus bacteremia'. Together they form a unique fingerprint.

Cite this